A simple shift in where new mothers receive care is helping the fight against hepatitis C. By bringing infectious…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has given Lion TCR the green light to start Phase 1b/2 clinical…
Exposure to excessive alcohol disrupts the activity of a protein that plays a key role in keeping liver fat healthy,…
A gene-editing therapy designed to specifically inactivate a hidden genetic blueprint of the hepatitis B virus (HBV) — the cause…
One year of treatment with saroglitazar, Zydus Therapeutics’ experimental oral candidate, outperformed a placebo at normalizing markers of liver…
Babies who had standard Kasai surgery when they were more than 60 days old or had spleen malformations were more…
A one-hour point-of-care test for hepatitis C has been cleared for use in Canada, which could help accelerate diagnosis…
The U.S. Food and Drug Administration (FDA) has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat certain people with…
India’s Central Drugs Standard Control Organization has approved the oral therapy nor-ursodeoxycholic acid (NorUDCA) for people with metabolic dysfunction-associated steatotic…
A new artificial intelligence (AI) algorithm can help identify babies with genetic forms of cholestasis, including progressive familial intrahepatic…